行情

VERU

VERU

VERU
NASDAQ

实时行情|Nasdaq Last Sale

1.900
-0.015
-0.78%
休市 16:00 09/13 EDT
开盘
1.900
昨收
1.915
最高
1.952
最低
1.890
成交量
7.34万
成交额
--
52周最高
2.490
52周最低
1.180
市值
1.24亿
市盈率(TTM)
-6.6364
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

VERU 新闻

  • 绝不延迟脱欧 英首相自比"绿巨人":越疯狂,就越强大
  • 环球网.1小时前
  • 沙特石油设施遇袭产量减半 美随时准备动用石油储备
  • 新京报网.2小时前
  • 新华国际时评:央行“放水”恐难纾欧元区之困
  • 新华网.2小时前
  • 沙特官员:周一石油产量将恢复到正常水平
  • 新浪美股.3小时前

更多

所属板块

制药
-0.54%
制药与医学研究
-0.38%

热门股票

名称
价格
涨跌幅

VERU 简况

Veru Inc., formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector. For men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout and sexual dysfunction. Women's Health has product candidates for female sexual health, and advanced breast and ovarian cancers. It manufactures, markets and sells the FC2 Female Condom. FC2 provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS).
展开

Webull提供Veru Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。